Search
for
Sort by
Research 421–450 of 1000+
- A Single Subcutaneous Dose of BMD-1141 Stimulates Hair Regrowth Comparable to Daily, High-Dose Ruxolitinib in a Mouse Model of Alopecia Areata.
- A Novel Topical Compound Gel Loading Minoxidil and Tofacitinib for Treatment of Alopecia Areata: Formulation, Characterization, and In Vitro/In Vivo Evaluation
- Wiederbehaarung bei einem Patienten mit Alopecia universalis und Psoriasis vulgaris unter Deucravacitinib‐Therapie
- Dual Relief: How Atopic Dermatitis Treatments Affect Alopecia Areata—A Small Retrospective Cohort Study
- Case Series: Gene Expression Analysis in Canine Vogt-Koyanagi-Harada/Uveodermatologic Syndrome and Vitiligo Reveals Conserved Immunopathogenesis Pathways Between Dog and Human Autoimmune Pigmentary Disorders
- MODERN BIOLOGICAL TREATMENT METHODS FOR ALOPECIA AREATA: A COMPREHENSIVE REVIEW
- Costunolide—A Bioactive Sesquiterpene Lactone with Diverse Therapeutic Potential
- The role of integrin alphavbeta6 in impaired wound healing and hair follicle regeneration
- PRP for Immune Mediated Alopecias (Alopecia Areata, Alopecia Totalis)
- Autoinmune Alopecia/Alopecia Areata
- Alopecia Areata: Clinical Treatment
- Systemic Therapies for Scarring and Non-scarring Alopecia
- Efficacy of Tofacitinib in the Treatment of Universal Alopecia Areata and Primary Sjögren Syndrome
- New Drugs for Alopecias
- Efficacy of derinat as a treatment for murine and androgenetic alopecia (AGA) patients
- A clinical case of familial alopecia areata in combination with immune pathology
- Abrocitinib Improved Dupilumab-Resistant Severe Atopic Dermatitis with Comorbid Mild Alopecia Areata in a 12-Year-Old Boy: A Case Report with 1-Year Follow-Up
- Upadacitinib for the Management of Alopecia Totalis and Subtotalis in Pediatric Patients: A Case Series
- Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients
- Chemistry42: An AI-Driven Platform for Molecular Design and Optimization
- Economic Burden of Alopecia Areata in the Kingdom of Saudi Arabia from a Societal Perspective: A Cost-of-Illness Analysis
- Clinicopathologic features, demographics, disease burden, and therapeutics in alopecic sarcoidosis: a case series and systematic review
- A phase 2a trial of brepocitinib for cicatricial alopecia
- Adipocytes in Skin Health and Disease
- Primary cicatricial alopecias are characterized by dysregulation of shared gene expression pathways
- Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata
- Treatment of alopecia areata with JAK inhibitors: a review of the literature
- Small Molecule Inhibitors and Inflammatory Skin Diseases
- Safety of oral JAK inhibitors in treating alopecia areata: a systematic review and network meta-analysis
- Efficacy, Safety, and Tolerability of Upadacitinib in Adults and Adolescents With Severe Alopecia Areata: Results From the Randomized, Placebo-Controlled, Double-Blind Phase 3 Program (UP-AA)